Presentation of Financial Information (Details) - USD ($)	Jan. 01, 2023	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accrued interest receivables for loans		$ 10,300,000	$ 9,800,000
Financing Receivable, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration]		Other Assets	Other Assets
Retained earnings		$ 160,085,000	$ 156,545,000
Allowance for loan losses	$ 31,989,000		23,334,000	$ 20,078,000	$ 19,352,000
Allowance for off balance sheet credit		3,200,000	85,000
Allowance recognized on loans purchased with credit deterioration	2,898,000
Entities minimum amount of financing receivable to evaluate individually		500,000
Other Liabilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for off balance sheet credit		$ 3,000,000.0
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for off balance sheet credit	3,000,000.0
Cumulative Effect, Period of Adoption, Adjustment [Member] | Accounting Standards Update 2016-13 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Retained earnings	6,600,000
Allowance for loan losses	5,757,000		$ 5,757,000
Aggregate allowance adjustment	8,700,000
Allowance for off balance sheet credit	3,000,000.0
Increase in deferred tax assets	2,300,000
Allowance recognized on loans purchased with credit deterioration	$ 2,900,000